Ads
related to: Abbvie- Read AbbVie Stories
Read Stories About Our Science,
People, and More Today.
- AbbVie News Center
See Our Achievements, Growth Story,
and More Today.
- Investor Resources
Find Financial Reports, Stock Info
And More Resources For Investors.
- Our Science
See How We Impact Lives.
More Than Developing Medicines.
- Read AbbVie Stories
Search results
Cencora data breach exposes US patient info from 8 drug companies
BleepingComputer· 2 days agoCencora, formerly AmerisourceBergen, is a pharmaceutical services provider specializing in drug...
Why AbbVie (ABBV) is a Top Value Stock for the Long-Term
Zacks· 3 days agoTaking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 22 hours agoNEW YORK, May 25, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between (Nasdaq: CERE) Cerevel Therapeutics Holdings, Inc. and AbbVie ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 4 days agoPortfolio companies have raised over US$ 600 million in equity capital. BASEL, Switzerland, May 22, 2024 /PRNewswire/ -- BaseLaunch, the Basel-based biotech venture incubator, today announces ...
A Must-Own Stock for Any Portfolio
Motley Fool via Yahoo Finance· 4 days agoWhen it comes to investing, I often look for companies that generate strong amounts of free cash flow (FCF), and companies that can grow their FCF. One...
Senators strike bipartisan tone on more pharma patent reforms
Endpoints News· 5 days agoThe issue of drug patent reform appears to have brought members from both sides of the aisle...
Add These Dividend Stocks To Your Portfolio To Boost Your Retirement Income, Plus 2 High-Yield...
Benzinga via Yahoo Finance· 4 days agoHigh-quality, low-risk dividend stocks offer a solid income stream while cushioning your portfolio...
Lilly (LLY) Hits Record High on Crohn's Disease Study Data
Zacks· 4 days agoFree Report) rose nearly 3% on Tuesday after it reported detailed one-year results from the phase III VIVID-1 study, which evaluated its IL-23p19 antibody mirikizumab in adults with Crohn’s ...
A Must-Own Stock for Any Portfolio | The Motley Fool
The Motley Fool· 4 days agoThis company offers growth, high yield, and dividend growth.
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to...
Morningstar· 2 days agoFN Media Group News Commentary - The pancreatic cancer market encompasses the pharmaceutical and healthcare sectors dedicated to addressing the prevention, diagnosis, and treatment of pancreatic ...
Ad
related to: Abbvie